Pharmacotherapy of Borderline Personality Disorder: A Systematic Review

E-ISSN： 1875-533x|18|22|3322-3329

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.22, 2011-08, pp. : 3322-3329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions

Current Pharmaceutical Design, Vol. 21, Iss. 23, 2015-01 ,pp. : 3311-3316

Bentham Science Publishers

Access to resources Recommend Favorite

Opioid addiction and borderline personality disorder

American Journal on Addictions, Vol. 27, Iss. 1, 2018-01 ,pp. : 54-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychobiological Model of Personality: Guidelines for Pharmacotherapy of Personality Disorder

By Svrakic Dragan M. C. Cloninger Robert

Current Psychopharmacology, Vol. 2, Iss. 3, 2013-08 ,pp. : 190-203

Bentham Science Publishers

Access to resources Recommend Favorite

Psychobiological Model of Personality: Guidelines for Pharmacotherapy of Personality Disorder

Current Psychopharmacology, Vol. 2, Iss. 3, 2013-08 ,pp. : 190-203

Bentham Science Publishers

Access to resources Recommend Favorite

Fluvoxamine improves affect lability in borderline personality disorder

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite